vs
Open Lending Corp（LPRO）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是Open Lending Corp的1.8倍（$35.5M vs $19.3M），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 134.0%），Open Lending Corp自由现金流更多（$-3.3M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs -20.7%）
开放图书馆是互联网档案馆旗下的非盈利在线项目，旨在实现「每一本出版过的书都拥有专属网页」的目标，由亚伦·斯沃茨等多位开发者共同创立，项目获得了加州州立图书馆和卡勒-奥斯汀基金会的部分资助，为用户提供多种格式的公开领域书籍数字化副本在线阅览服务。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
LPRO vs RXRX — 直观对比
营收规模更大
RXRX
是对方的1.8倍
$19.3M
营收增速更快
RXRX
高出547.8%
134.0%
自由现金流更多
LPRO
多$44.1M
$-47.3M
两年增速更快
RXRX
近两年复合增速
-20.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $19.3M | $35.5M |
| 净利润 | — | $-108.1M |
| 毛利率 | 76.0% | 59.8% |
| 营业利润率 | 3.9% | -304.8% |
| 净利率 | — | -304.2% |
| 营收同比 | 134.0% | 681.7% |
| 净利润同比 | — | 39.6% |
| 每股收益（稀释后） | $-0.00 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LPRORXRX
| Q4 25 | $19.3M | $35.5M | ||
| Q3 25 | $24.2M | $5.2M | ||
| Q2 25 | $25.3M | $19.2M | ||
| Q1 25 | $24.4M | $14.7M | ||
| Q4 24 | $-56.9M | $4.5M | ||
| Q3 24 | $23.5M | $26.1M | ||
| Q2 24 | $26.7M | $14.4M | ||
| Q1 24 | $30.7M | $13.8M |
净利润LPRORXRX
| Q4 25 | — | $-108.1M | ||
| Q3 25 | $-7.6M | $-162.3M | ||
| Q2 25 | $1.0M | $-171.9M | ||
| Q1 25 | $617.0K | $-202.5M | ||
| Q4 24 | — | $-178.9M | ||
| Q3 24 | $1.4M | $-95.8M | ||
| Q2 24 | $2.9M | $-97.5M | ||
| Q1 24 | $5.1M | $-91.4M |
毛利率LPRORXRX
| Q4 25 | 76.0% | 59.8% | ||
| Q3 25 | 78.0% | -183.8% | ||
| Q2 25 | 78.2% | -4.9% | ||
| Q1 25 | 75.1% | -48.0% | ||
| Q4 24 | 111.0% | -181.4% | ||
| Q3 24 | 73.9% | 53.7% | ||
| Q2 24 | 78.6% | 36.2% | ||
| Q1 24 | 81.3% | 19.1% |
营业利润率LPRORXRX
| Q4 25 | 3.9% | -304.8% | ||
| Q3 25 | -31.9% | -3327.6% | ||
| Q2 25 | 4.6% | -916.8% | ||
| Q1 25 | 3.1% | -1297.9% | ||
| Q4 24 | 138.0% | -4042.4% | ||
| Q3 24 | 7.9% | -377.1% | ||
| Q2 24 | 14.9% | -697.4% | ||
| Q1 24 | 23.8% | -698.4% |
净利率LPRORXRX
| Q4 25 | — | -304.2% | ||
| Q3 25 | -31.3% | -3135.3% | ||
| Q2 25 | 4.1% | -894.2% | ||
| Q1 25 | 2.5% | -1373.3% | ||
| Q4 24 | — | -3935.5% | ||
| Q3 24 | 6.1% | -367.5% | ||
| Q2 24 | 10.9% | -676.6% | ||
| Q1 24 | 16.5% | -662.4% |
每股收益（稀释后）LPRORXRX
| Q4 25 | $-0.00 | $-0.17 | ||
| Q3 25 | $-0.06 | $-0.36 | ||
| Q2 25 | $0.01 | $-0.41 | ||
| Q1 25 | $0.01 | $-0.50 | ||
| Q4 24 | $-1.20 | $-0.56 | ||
| Q3 24 | $0.01 | $-0.34 | ||
| Q2 24 | $0.02 | $-0.40 | ||
| Q1 24 | $0.04 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $176.6M | $743.3M |
| 总债务越低越好 | $84.8M | $9.6M |
| 股东权益账面价值 | $75.0M | $1.1B |
| 总资产 | $236.7M | $1.5B |
| 负债/权益比越低杠杆越低 | 1.13× | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资LPRORXRX
| Q4 25 | $176.6M | $743.3M | ||
| Q3 25 | $222.1M | $659.8M | ||
| Q2 25 | $230.7M | $525.1M | ||
| Q1 25 | $236.2M | $500.5M | ||
| Q4 24 | $243.2M | $594.4M | ||
| Q3 24 | $250.2M | $427.6M | ||
| Q2 24 | $248.0M | $474.3M | ||
| Q1 24 | $247.0M | $296.3M |
总债务LPRORXRX
| Q4 25 | $84.8M | $9.6M | ||
| Q3 25 | $134.4M | $11.9M | ||
| Q2 25 | $136.1M | $14.2M | ||
| Q1 25 | $137.9M | $16.4M | ||
| Q4 24 | $139.7M | $19.0M | ||
| Q3 24 | $141.5M | $20.5M | ||
| Q2 24 | $143.3M | $22.9M | ||
| Q1 24 | $143.2M | — |
股东权益LPRORXRX
| Q4 25 | $75.0M | $1.1B | ||
| Q3 25 | $72.8M | $1.0B | ||
| Q2 25 | $78.9M | $919.1M | ||
| Q1 25 | $79.8M | $933.9M | ||
| Q4 24 | $78.1M | $1.0B | ||
| Q3 24 | $220.5M | $524.6M | ||
| Q2 24 | $216.8M | $584.4M | ||
| Q1 24 | $211.5M | $401.2M |
总资产LPRORXRX
| Q4 25 | $236.7M | $1.5B | ||
| Q3 25 | $287.7M | $1.4B | ||
| Q2 25 | $296.7M | $1.3B | ||
| Q1 25 | $304.2M | $1.3B | ||
| Q4 24 | $296.4M | $1.4B | ||
| Q3 24 | $395.7M | $726.5M | ||
| Q2 24 | $382.8M | $775.9M | ||
| Q1 24 | $380.6M | $557.8M |
负债/权益比LPRORXRX
| Q4 25 | 1.13× | 0.01× | ||
| Q3 25 | 1.84× | 0.01× | ||
| Q2 25 | 1.72× | 0.02× | ||
| Q1 25 | 1.73× | 0.02× | ||
| Q4 24 | 1.79× | 0.02× | ||
| Q3 24 | 0.64× | 0.04× | ||
| Q2 24 | 0.66× | 0.04× | ||
| Q1 24 | 0.68× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-3.2M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $-3.3M | $-47.3M |
| 自由现金流率自由现金流/营收 | -16.8% | -133.1% |
| 资本支出强度资本支出/营收 | 0.3% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-378.3M |
8季度趋势，按日历期对齐
经营现金流LPRORXRX
| Q4 25 | $-3.2M | $-46.1M | ||
| Q3 25 | $-5.7M | $-117.4M | ||
| Q2 25 | $848.0K | $-76.4M | ||
| Q1 25 | $-3.8M | $-132.0M | ||
| Q4 24 | $17.6M | $-115.4M | ||
| Q3 24 | $11.4M | $-59.2M | ||
| Q2 24 | $-1.4M | $-82.2M | ||
| Q1 24 | $11.0M | $-102.3M |
自由现金流LPRORXRX
| Q4 25 | $-3.3M | $-47.3M | ||
| Q3 25 | — | $-117.6M | ||
| Q2 25 | $837.0K | $-79.6M | ||
| Q1 25 | $-3.9M | $-133.8M | ||
| Q4 24 | $17.4M | $-116.7M | ||
| Q3 24 | $11.3M | $-63.8M | ||
| Q2 24 | $-1.5M | $-83.4M | ||
| Q1 24 | — | $-109.0M |
自由现金流率LPRORXRX
| Q4 25 | -16.8% | -133.1% | ||
| Q3 25 | — | -2272.5% | ||
| Q2 25 | 3.3% | -413.9% | ||
| Q1 25 | -15.9% | -907.4% | ||
| Q4 24 | -30.6% | -2567.7% | ||
| Q3 24 | 48.0% | -244.6% | ||
| Q2 24 | -5.5% | -578.5% | ||
| Q1 24 | — | -789.9% |
资本支出强度LPRORXRX
| Q4 25 | 0.3% | 3.5% | ||
| Q3 25 | 0.0% | 4.7% | ||
| Q2 25 | 0.0% | 16.4% | ||
| Q1 25 | 0.2% | 12.4% | ||
| Q4 24 | -0.3% | 28.6% | ||
| Q3 24 | 0.5% | 17.5% | ||
| Q2 24 | 0.2% | 8.2% | ||
| Q1 24 | 0.0% | 48.2% |
现金转化率LPRORXRX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.82× | — | ||
| Q1 25 | -6.22× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 7.92× | — | ||
| Q2 24 | -0.48× | — | ||
| Q1 24 | 2.16× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
